As of November 2024, Axsome Therapeutics has a market cap of $4.36B. This makes Axsome Therapeutics the world's 3070th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.38B | 16.30% |
2023 | $3.77B | 3.19% |
2022 | $3.65B | 104.16% |
2021 | $1.79B | -53.63% |
2020 | $3.86B | -21.18% |
2019 | $4.89B | 3565.25% |
2018 | $133.44M | -49.64% |
2017 | $264.99M | -17.04% |
2016 | $319.41M | -27.18% |
2015 | $438.65M | - |